Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

14.60 -0.19 (-1.28%)

Streaming Delayed Price Updated: 10:43 AM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	119,398
Open	14.85
Bid (Size)	14.55 (600)
Ask (Size)	14.60 (400)
Prev. Close	14.79
Today's Range	14.45 - 15.09
52wk Range	4.190 - 17.58
Shares Outstanding	107,808,471
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Silence Therapeutics to Participate in Three September Investor Conferences

September 02, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

August 14, 2026

From Silence Therapeutics plc

Via Business Wire

Performance

YTD	+137.4%	+137.4%
1 Month	+36.7%	+36.7%
3 Month	+127.8%	+127.8%
6 Month	+152.6%	+152.6%
1 Year	+206.1%	+206.1%

More News

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

August 11, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial ↗

August 11, 2026

Via MarketBeat

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

August 10, 2026

From Silence Therapeutics plc

Via Business Wire

There are notable gap-ups and gap-downs in today's session. ↗

August 10, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

August 10, 2026

Via Chartmill

Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

August 10, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

August 10, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

August 09, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

June 11, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

May 27, 2026

From Silence Therapeutics plc

Via Business Wire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 12, 2026

Via Chartmill

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

May 12, 2026

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results

May 07, 2026

From Silence Therapeutics plc

Via Business Wire

Keep an eye on the top gainers and losers in Wednesday's session. ↗

May 06, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

April 29, 2026

Via Chartmill

Top movers in Thursday's session ↗

April 23, 2026

Via Chartmill

Monday's session: gap up and gap down stocks ↗

April 06, 2026

Via Chartmill

Here are the top movers in Monday's session. ↗

March 30, 2026

Via Chartmill

Top stock movements in today's session. ↗

March 27, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

March 27, 2026

Via Chartmill

Which stocks are gapping on Friday? ↗

March 27, 2026

Via Chartmill

Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗

March 26, 2026

Via Chartmill

Here are the top movers in Thursday's session. ↗

March 26, 2026

Via Chartmill

Frequently Asked Questions

Is Silence Therapeutics Plc - American Depository Share publicly traded?

Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.

What exchange does Silence Therapeutics Plc - American Depository Share trade on?

Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market

What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?

The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market

What is the current price of Silence Therapeutics Plc - American Depository Share?

The current price of Silence Therapeutics Plc - American Depository Share is 14.60

When was Silence Therapeutics Plc - American Depository Share last traded?

The last trade of Silence Therapeutics Plc - American Depository Share was at 09/03/26 10:43 AM ET

What is the market capitalization of Silence Therapeutics Plc - American Depository Share?

The market capitalization of Silence Therapeutics Plc - American Depository Share is 1.57B

How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?

Silence Therapeutics Plc - American Depository Share has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.